Introduction: Umbilical cord blood is blood left over in the placenta and in the umbilical cord after the birth of the baby. Umbilical cord blood saving consists of the collection, processing and cryopreservation of the remaining blood within the umbilicus and placenta following the birth of a child. Within this left over blood, traditionally discarded with the placenta as medical waste, lies a rich source of haematopoietic stem cells same as bone marrow. Cord blood stem cells have advantages over bone marrow in transplants and have been used in more than 30,000 transplants to regenerate healthy blood and immune systems1. Today, stem cell therapies continue to evolve, bringing new hope to patients and their families.Objective: To aware regarding use of stem cells of babys umbilical cord blood in future.Methods: A review of relevant articles and documents and some world standard stem cell banking protocol were undertaken.Conclusion: When these cord blood stem cells are processed and stored, the cells are not only a perfect match for the baby, but it could also provide life saving benefits for siblings and other family members.Bangladesh J Obstet Gynaecol, 2012; Vol. 27(2) : 79-82
Stillbirth and early neonatal death is quite high in Bangladesh. The current study was undertaken to find out sociodemographic and pregnancy related risk factors that may exist with cases of stillbirth and death during first 7 days of life. This was a cross sectional study conducted at Institute of Child and mother health (ICMH) between February to June 2015. Mothers delivered still birth baby at ICMH and whose babies were admitted in neonatal ward immediately after birth for delay to cry were enrolled consecutively. Data was collected by interviewing mothers and reviewing hospital records using structured questionnaire. Follow up was done till 7 days. Data analysis was done with SPSS version 14 Among a total 116 mothers 83.6% came from rural areas, 48.2% belong to 20-25 years age group with mean age 23±5 year, 46.6% had primary education, 89.7% were primipara, and 62.9% had more than 4 antenatal visits in index pregnancy. Common pregnancy related problems were anaemia (85.3%), preeclampsia (41.4%), less fetal movement (31.9%), polyhydramnios (13.8%), oligohydramnios (12.9%), premature rupture membrane (58.6%), prolong labour 48.3%), malpresentation (8.6%) and urinary tract infection in 12.1%. About 69.8% delivered at hospital, 59% had normal vaginal delivery, instrumental delivery 17.2% and caesarean section in 24.1%. About 57.8% babies were born preterm. and 55.1% were low birth weight. During first 7 days of life 32% developed neonatal sepsis and 32.8% died. Cause of death as recorded was perinatal asphyxia (55.17%), hypoxic ischemic encephalopathy 17.2%, low birth weight with perinatal asphyxia in 35.6% and meconium aspiration syndrome 4.5%. Stillbirth and early neonatal deaths are obstetric catastrophe and has common overlapping risk factors. Risk specific interventions with special emphasis on improvement of quality of care throughout the phases of pregnancy, delivery and postpartum period is recommended Bangladesh J Obstet Gynaecol, 2021; Vol. 36(1): 10-17
Stereotactic radiosurgery (SRS) has been widely used for the treatment of intracranial lesions. We have been doing SRS since March 2019. The unique ability of SRS to deliver higher focused dose to the smaller targets preferably in a single exposure in a convenient manner while sparing adjacent critical structures has made a more widely adopted treatment option. This case series is intended to show our institutional experience and procedural technique adapted for treating intracranial meningioma using SRS by Linear accelerators. We present five cases of intracranial meningioma. Four had Grade I meningioma and one patient with Grade III meningioma. One patient had radiological diagnosis only and treated with SRS. Two patients underwent gross total resection and SRS was prescribed on the event of recurrence. Rest two patients had recurrence/progression after subtotal resection and adjuvant radiation. The dose prescription ranged from 13 to 21Gy in one to three fractions which was determined by tumor volume, location, grade, proximity to critical structures, pre-existing neurologic impairment, previous treatment history, time to progression/relapse and the ideal balance of prescription dosage and expected problems. There were no acute side effects from any of the procedures. All five patients had improvement in clinical symptoms in the immediate post-SRS period. One patient who has two-year post-SRS revealed a significant regression in the size of the tumor. This case series summarizes the fact that SRS for intracranial meningioma is safe and effective treatment strategy when appropriate. Pulse Volume 12-14 2020-2022 p.40-52
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.